Click for article
A patient safety alert has been issued by NHS England to support providers of NHS funded care to minimise the risk of distress and death caused by inappropriate doses of naloxone.
The new ‘Stage 2: Resource’ alert highlights a number of resources now available to help providers ensure their local protocols and training related to naloxone reflect best practice.
A combination drug treatment can reduce agitation in patients with probable Alzheimer’s disease and is generally well tolerated, preliminary research published in JAMA has shown.
Click for article
The phase II double blind randomised clinical trial showed that patients who received the combination dextromethorphan hydrobromide and quinidine sulphate had lower occurrence and severity of agitation than patients who received placebo. This combination is approved in the United States and the European Union for treating pseudobulbar affect, a neurological disorder characterised by uncontrollable episodes of crying.
Click here for article
From 1 July 2015, new EU rules will require on-line pharmacies to display a common logo to ensure the authenticity of the medicines they sell, to help protect patients from the possible harmful effects of falsified medicines.
Falsified medicines are fake medicines that pass themselves off as real, authorised medicine and which might contain ingredients which are of bad quality or in the wrong dose and, as such, are a major threat to public health
Pharmacy staff and students of East Cheshire NHS Trust are invited to view a new page on our website and assist in its development. Your comments and suggestions are invited to help make it as useful as possible. The website is externally hosted and is available 24/7.
Please email your comments to Jan Read Thank you
Our thanks to Ciaran Friel of Liverpool Community Health NHS Trust for this news.
The Centre for Pharmacy Postgraduate Education (CPPE) has launched the Medicines Safety app. This is free and funded by Health Education North West. It offers short quizzes for any healthcare professional to test their knowledge on high-risk areas for medicines safety incidents. The topics so far include: Insulin, Allergies, Opioids, Anticoagulation and Medicines safety.
It stimulates further learning so it can be used to generate ideas for CPD portfolios and to improve practice. You can also use it in group learning situations as a starting point for discussion on key safety issues.
Download the app free of charge from the App Store for iPhone/iPad users and from Google Play Store for Android devices. More topics will be released soon.
You can also keep up to date with developments at CPPE and get in touch via the following media: www.cppe.ac.uk/blog or via Twitter at twitter.com/cppeengland
BMA agree to negotiations on junior doctors contract
The BMA Junior Doctors Committee has announced today (22 July 2013) that it is willing to negotiate with employers on a new contract of employment for junior doctors.
This bulletin is brought to you via The King’s Fund.
Community pharmacy news, January 2013
From 1st July 2012, new data capture requirements for the community pharmacy MUR service will be implemented. There are also planned changes to the requirement to inform the patient’s GP that an MUR has taken place but the implementation of these changes is subject to the amendment of the relevant Directions.
Pharmacists have a professional, legal and moral duty to protect children from abuse or neglect and to work with other organisations and authorities to safeguard children. The purpose of this resource is to provide concise practical information to help pharmacists protect children and young people in the course of their professional practice.
It provides information in three key areas:
• Recognising signs of abuse or neglect
• What to do if abuse or neglect is suspected
• Sources of further information and advice
Click here to view the Protecting Children and Young People quick reference guide »